MNMD - Mind Medicine  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNMD is currently covered by 6 analysts with an average price target of $24.83. This is a potential upside of $15.47 (165.28%) from yesterday's end of day stock price of $9.36.

Mind Medicine 's activity chart (see below) currently has 11 price targets and 41 ratings on display. The stock rating distribution of MNMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30% with an average time for these price targets to be met of 166 days.

Highest price target for MNMD is $55, Lowest price target is $14, average price target is $27.75.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 07-Mar-2025. First documented stock forecast 28-Jun-2021.

Currently out of the existing stock ratings of MNMD, 25 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$55

$45.91 (505.06%)

4 months 28 days ago
(07-Mar-2025)

2/6 (33.33%)

$48.17 (705.27%)

165

Buy

$20

$10.91 (120.02%)

$20

7 months 18 days ago
(17-Dec-2024)

0/5 (0%)

$12.52 (167.38%)

Buy

$14

$4.91 (54.02%)

$16

10 months 19 days ago
(16-Sep-2024)

0/2 (0%)

$7.64 (120.13%)

Buy

$7

1 years 1 months 14 days ago
(21-Jun-2024)

2/3 (66.67%)

$2.89 (70.32%)

246

Buy

$22

$12.91 (142.02%)

$22

1 years 1 months 30 days ago
(05-Jun-2024)

6/10 (60%)

$14.58 (196.50%)

272

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MNMD (Mind Medicine ) average time for price targets to be met?

On average it took 166 days on average for the stock forecasts to be realized with a an average price target met ratio 30

Which analyst has the current highest performing score on MNMD (Mind Medicine ) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the current lower performing score on MNMD (Mind Medicine ) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on MNMD (Mind Medicine )?

Patrick Trucchio has 11 price targets and 10 ratings on MNMD

Which analyst is the currently most bullish on MNMD (Mind Medicine )?

Patrick Trucchio with highest potential upside - $45.91

Which analyst is the currently most reserved on MNMD (Mind Medicine )?

Jason Mccarthy with lowest potential downside - -$1.89

Mind Medicine  in the News

MindMed (MNMD) Q2 Net Loss Jumps 625%

Key Points GAAP EPS loss of $0.50 in Q2 2025 missed consensus estimates, with Net loss for the quarter ended June 30, 2025, was $42.7 million, compared to $5.9 million in 2024. Research and development expenses doubled in Q2 2025, primarily due to late-stage clinical trial activity for MM120. Cash and investments of $237.9 million...

Earnings call transcript: MindMed Q2 2025 reveals cash runway into 2027

Mind Medicine Inc (MNMD), with a market capitalization of $686.4 million, reported its second-quarter earnings for 2025, highlighting a strong cash position and ongoing investment in research and development. The company’s earnings per share (EPS) came in at -$0.50, missing the forecast of -$0.37 by 35.14%. Despite this, the stock rose by 2.99% in aftermarket...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?